Top Chinese Drugmaker Makes Successful Debut, raises $6.5 Billion in the Hong Kong IPO
Listing in the Hong Kong market was a crucial step for Hengrui, which could now enter the global capital market and fasten its globalisation process. Jiangsu Hengrui Pharmaceuticals, one of…